BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4093900)

  • 1. Plasma fibrinogen--a major coronary risk factor.
    Stone MC; Thorp JM
    J R Coll Gen Pract; 1985 Dec; 35(281):565-9. PubMed ID: 4093900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous humor perturbations in chronic smokers: a proteomic study.
    Amer R; Koriat A
    Sci Rep; 2024 May; 14(1):11279. PubMed ID: 38760463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irregularities of Coagulation in Hypertension.
    Rafaqat S; Khalid A; Riaz S; Rafaqat S
    Curr Hypertens Rep; 2023 Oct; 25(10):271-286. PubMed ID: 37561240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII Activity in Relation to the Type of Thrombosis and Patient's Risk Factors for Thrombosis, Age, and Comorbidity.
    Basaric D; Saracevic M; Bosnic V; Vlatkovic A; Tomic B; Kovac M
    Eurasian J Med; 2023 Feb; 55(1):9-13. PubMed ID: 36861859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between ischemic stroke and pyogenic spondylitis in Korea: Nationwide longitudinal cohort study.
    Lee SH; Kim H; Han IB; Sheen SH; Hong JB; Sohn S
    J Cerebrovasc Endovasc Neurosurg; 2023 Jun; 25(2):143-149. PubMed ID: 36647233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between 25-Hydroxyvitamin D and Total and γ' Fibrinogen and Plasma Clot Properties and Gene Interactions in a Group of Healthy Black South African Women.
    Rautenbach PH; Nienaber-Rousseau C; de Lange-Loots Z; Kruger IM; Pieters M
    Front Cardiovasc Med; 2022; 9():868542. PubMed ID: 35903674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Effects of Diets Rich in Polyphenols in Cigarette Smoke (CS)-Induced Oxidative Damages and Associated Health Implications.
    Rudrapal M; Maji S; Prajapati SK; Kesharwani P; Deb PK; Khan J; Mohamed Ismail R; Kankate RS; Sahoo RK; Khairnar SJ; Bendale AR
    Antioxidants (Basel); 2022 Jun; 11(7):. PubMed ID: 35883708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between fibrinogen levels and the risk of cardiovascular disease and all-cause death: a cohort study from the Chin-Shan community in Taiwan.
    Hsieh CT; Chien KL; Hsu HC; Lin HJ; Su TC; Chen MF; Lee YT
    BMJ Open; 2022 Apr; 12(4):e054638. PubMed ID: 35365526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of fibrinogen-to-albumin ratio in predicting 1-year clinical progression in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention.
    He D; Jiao Y; Yu T; Song J; Wen Z; Wu J; Duan W; Sun N; Sun Z; Sun Z
    Exp Ther Med; 2019 Oct; 18(4):2972-2978. PubMed ID: 31555382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.
    Conklin DJ; Schick S; Blaha MJ; Carll A; DeFilippis A; Ganz P; Hall ME; Hamburg N; O'Toole T; Reynolds L; Srivastava S; Bhatnagar A
    Am J Physiol Heart Circ Physiol; 2019 Apr; 316(4):H801-H827. PubMed ID: 30707616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dark nights behind the white clouds - risks of tobacco smoking on human health besides the oral health and malignancy.
    Zainul Z
    EXCLI J; 2011; 10():69-84. PubMed ID: 29033703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orphan nuclear receptor ERRγ is a key regulator of human fibrinogen gene expression.
    Zhang Y; Kim DK; Lu Y; Jung YS; Lee JM; Kim YH; Lee YS; Kim J; Dewidar B; Jeong WI; Lee IK; Cho SJ; Dooley S; Lee CH; Li X; Choi HS
    PLoS One; 2017; 12(7):e0182141. PubMed ID: 28750085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk.
    King CC; Piper ME; Gepner AD; Fiore MC; Baker TB; Stein JH
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):374-379. PubMed ID: 27932354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over 50 Years of Fibrinogen Concentrate.
    Costa-Filho R; Hochleitner G; Wendt M; Teruya A; Spahn DR
    Clin Appl Thromb Hemost; 2016 Mar; 22(2):109-14. PubMed ID: 26294722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prothrombin time and activated partial thromboplastin time in hypertensive patients attending a tertiary hospital in calabar, Nigeria.
    Nnenna Adaeze N; Uchenna Emeribe A; Abdullahi Nasiru I; Babayo A; Uko EK
    Adv Hematol; 2014; 2014():932039. PubMed ID: 25477963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery.
    Solomon C; Hagl C; Rahe-Meyer N
    Br J Anaesth; 2013 Jun; 110(6):947-56. PubMed ID: 23388508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biology behind the atherothrombotic effects of cigarette smoke.
    Csordas A; Bernhard D
    Nat Rev Cardiol; 2013 Apr; 10(4):219-30. PubMed ID: 23380975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma fibrinogen, tissue plasminogen activator, plasminogen activator inhibitor 1, and their related factors in three Japanese population samples.
    Koike KA; Iso H; Shimamoto T; Kudo M; Umemura U; Sato S; Naito Y; Iida M; Komachi Y
    Environ Health Prev Med; 1998 Oct; 3(3):158-63. PubMed ID: 21432496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of fibrinogen biosynthesis: role of the FFA/albumin ratio.
    Pilgeram L
    Cardiovasc Eng; 2010 Jun; 10(2):78-83. PubMed ID: 20383582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review.
    Tziomalos K; Athyros VG
    Int J Nanomedicine; 2006; 1(2):129-47. PubMed ID: 17722529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.